Yanagawa Takashi, Funasaka Tatsuyoshi, Tsutsumi Soichi, Raz Tirza, Tanaka Nobutada, Raz Avraham
Tumor Progression and Metastasis Program, Karmanos Cancer Institute, 110 E. Warren Ave., Detroit, Michigan 48201, USA.
J Biol Chem. 2005 Mar 18;280(11):10419-26. doi: 10.1074/jbc.M409457200. Epub 2005 Jan 5.
Phosphoglucose isomerase (PGI; EC 5.3.1.9) is a cytosolic housekeeping enzyme of the sugar metabolism pathways that plays a key role in both glycolysis and gluconeogenesis. PGI is a multifunctional dimeric protein that extracellularly acts as a cytokine with properties that include autocrine motility factor (AMF)-eliciting mitogenic, motogenic, and differentiation functions, and PGI has been implicated in tumor progression and metastasis. Little is known of the biochemical regulation of PGI/AMF activities, although it is known that human PGI/AMF is phosphorylated at Ser(185) by protein kinase CK2 (CK2); however, the physiological significance of this phosphorylation is unknown. Thus, by site-directed mutagenesis, we substituted Ser(185) with aspartic acid (S185D) or glutamic acid (S185E), which introduces a negative charge and conformational changes that mimic phosphorylation. A Ser-to-Ala mutant protein (S185A) was generated to abolish phosphorylation. Biochemical analyses revealed that the phosphorylation mutant proteins of PGI exhibited decreased enzymatic activity, whereas the S185A mutant PGI protein retained full enzymatic activity. PGI phosphorylation by CK2 also led to down-regulation of enzymatic activity. Furthermore, CK2 knockdown by RNA interference was associated with up-regulation of cellular PGI enzymatic activity. The three recombinant mutant proteins exhibited indistinguishable cytokine activity and receptor-binding affinities compared with the wild-type protein. In both in vitro and in vivo assays, the wild-type and S185A mutant proteins underwent active species dimerization, whereas both the S185D and S185E mutant proteins also formed tetramers. These results demonstrate that phosphorylation affects the allosteric kinetic properties of the enzyme, resulting in a less active form of PGI, whereas non-phosphorylated protein species retain cytokine activity. The process by which phosphorylation modulates the enzymatic activity of PGI thus has an important implication for the understanding of the biological regulation of this key glucose metabolism-regulating enzyme.
磷酸葡萄糖异构酶(PGI;EC 5.3.1.9)是糖代谢途径中的一种胞质管家酶,在糖酵解和糖异生过程中均发挥关键作用。PGI是一种多功能二聚体蛋白,在细胞外作为一种细胞因子发挥作用,具有包括引发自分泌运动因子(AMF)的促有丝分裂、促运动和分化功能,并且PGI与肿瘤进展和转移有关。尽管已知人PGI/AMF在丝氨酸(Ser)185位点被蛋白激酶CK2(CK2)磷酸化,但对PGI/AMF活性的生化调节知之甚少;然而,这种磷酸化的生理意义尚不清楚。因此,通过定点诱变,我们将丝氨酸185替换为天冬氨酸(S185D)或谷氨酸(S185E),这会引入一个负电荷并产生模拟磷酸化的构象变化。生成了一个丝氨酸到丙氨酸的突变蛋白(S185A)以消除磷酸化。生化分析表明,PGI的磷酸化突变蛋白表现出酶活性降低,而S185A突变型PGI蛋白保留了完整的酶活性。CK2对PGI的磷酸化也导致酶活性下调。此外,RNA干扰导致的CK2敲低与细胞PGI酶活性上调相关。与野生型蛋白相比,这三种重组突变蛋白表现出难以区分的细胞因子活性和受体结合亲和力。在体外和体内试验中,野生型和S185A突变蛋白都经历了活性物种二聚化,而S185D和S185E突变蛋白也形成了四聚体。这些结果表明,磷酸化影响该酶的别构动力学性质,导致PGI形成活性较低的形式,而非磷酸化的蛋白物种保留细胞因子活性。因此,磷酸化调节PGI酶活性的过程对于理解这种关键的葡萄糖代谢调节酶的生物学调节具有重要意义。